129 related articles for article (PubMed ID: 17998165)
1. Benzenesulfonamide indole inhibitors of cytosolic phospholipase A2alpha: optimization of in vitro potency and rat pharmacokinetics for oral efficacy.
Lee KL; Behnke ML; Foley MA; Chen L; Wang W; Vargas R; Nunez J; Tam S; Mollova N; Xu X; Shen MW; Ramarao MK; Goodwin DG; Nickerson-Nutter CL; Abraham WM; Williams C; Clark JD; McKew JC
Bioorg Med Chem; 2008 Feb; 16(3):1345-58. PubMed ID: 17998165
[TBL] [Abstract][Full Text] [Related]
2. 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
Fritsche A; Elfringhoff AS; Fabian J; Lehr M
Bioorg Med Chem; 2008 Apr; 16(7):3489-500. PubMed ID: 18321717
[TBL] [Abstract][Full Text] [Related]
3. Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitors.
Chen L; Wang W; Lee KL; Shen MW; Murphy EA; Zhang W; Xu X; Tam S; Nickerson-Nutter C; Goodwin DG; Clark JD; McKew JC
J Med Chem; 2009 Feb; 52(4):1156-71. PubMed ID: 19178292
[TBL] [Abstract][Full Text] [Related]
4. 1-(5-Carboxyindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis and properties of bioisosteric benzimidazole, benzotriazole and indazole analogues.
Bovens S; Kaptur M; Elfringhoff AS; Lehr M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2107-11. PubMed ID: 19327988
[TBL] [Abstract][Full Text] [Related]
5. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
6. Benzhydrylquinazolinediones: novel cytosolic phospholipase A2alpha inhibitors with improved physicochemical properties.
Kirincich SJ; Xiang J; Green N; Tam S; Yang HY; Shim J; Shen MW; Clark JD; McKew JC
Bioorg Med Chem; 2009 Jul; 17(13):4383-405. PubMed ID: 19482480
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.
Lee KL; Foley MA; Chen L; Behnke ML; Lovering FE; Kirincich SJ; Wang W; Shim J; Tam S; Shen MW; Khor S; Xu X; Goodwin DG; Ramarao MK; Nickerson-Nutter C; Donahue F; Ku MS; Clark JD; McKew JC
J Med Chem; 2007 Mar; 50(6):1380-400. PubMed ID: 17305324
[TBL] [Abstract][Full Text] [Related]
8. 1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity.
Drews A; Bovens S; Roebrock K; Sunderkötter C; Reinhardt D; Schäfers M; van der Velde A; Schulze Elfringhoff A; Fabian J; Lehr M
J Med Chem; 2010 Jul; 53(14):5165-78. PubMed ID: 20583844
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors.
Ramarao MK; Shen MW; Murphy EA; Duan W; Zhao Y; McKew J; Lee KL; Thakker P; Behnke ML; Clark JD
Anal Biochem; 2008 Dec; 383(2):217-25. PubMed ID: 18801329
[TBL] [Abstract][Full Text] [Related]
10. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
Zahov S; Drews A; Hess M; Schulze Elfringhoff A; Lehr M
ChemMedChem; 2011 Mar; 6(3):544-9. PubMed ID: 21259444
[TBL] [Abstract][Full Text] [Related]
11. Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib.
McKew JC; Lee KL; Shen MW; Thakker P; Foley MA; Behnke ML; Hu B; Sum FW; Tam S; Hu Y; Chen L; Kirincich SJ; Michalak R; Thomason J; Ipek M; Wu K; Wooder L; Ramarao MK; Murphy EA; Goodwin DG; Albert L; Xu X; Donahue F; Ku MS; Keith J; Nickerson-Nutter CL; Abraham WM; Williams C; Hegen M; Clark JD
J Med Chem; 2008 Jun; 51(12):3388-413. PubMed ID: 18498150
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies on 1-(2-oxopropyl)indole-5-carboxylic acids acting as inhibitors of cytosolic phospholipase A
Arnsmann M; Hanekamp W; Elfringhoff AS; Lehr M
Eur J Med Chem; 2017 Jan; 125():1107-1114. PubMed ID: 27810597
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.
Tomoo T; Nakatsuka T; Katayama T; Hayashi Y; Fujieda Y; Terakawa M; Nagahira K
J Med Chem; 2014 Sep; 57(17):7244-62. PubMed ID: 25102418
[TBL] [Abstract][Full Text] [Related]
14. Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure.
Fabian J; Hanekamp W; Thomas MH; Olivier JL; Lehr M
Chem Biol Interact; 2013 Nov; 206(2):356-63. PubMed ID: 24120545
[TBL] [Abstract][Full Text] [Related]
15. 1-(5-Carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A2α: effect of substituents in position 3 of the indole scaffold on inhibitory potency, metabolic stability, solubility, and bioavailability.
Bovens S; Schulze Elfringhoff A; Kaptur M; Reinhardt D; Schäfers M; Lehr M
J Med Chem; 2010 Dec; 53(23):8298-308. PubMed ID: 21067218
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytosolic phospholipase A2alpha: hit to lead optimization.
McKew JC; Foley MA; Thakker P; Behnke ML; Lovering FE; Sum FW; Tam S; Wu K; Shen MW; Zhang W; Gonzalez M; Liu S; Mahadevan A; Sard H; Khor SP; Clark JD
J Med Chem; 2006 Jan; 49(1):135-58. PubMed ID: 16392799
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of an inhibitor of cytosolic phospholipase A2α for the treatment of asthma.
Hewson CA; Patel S; Calzetta L; Campwala H; Havard S; Luscombe E; Clarke PA; Peachell PT; Matera MG; Cazzola M; Page C; Abraham WM; Williams CM; Clark JD; Liu WL; Clarke NP; Yeadon M
J Pharmacol Exp Ther; 2012 Mar; 340(3):656-65. PubMed ID: 22160268
[TBL] [Abstract][Full Text] [Related]
19. Ser515 phosphorylation-independent regulation of cytosolic phospholipase A2alpha (cPLA2alpha) by calmodulin-dependent protein kinase: possible interaction with catalytic domain A of cPLA2alpha.
Shimizu M; Nakamura H; Hirabayashi T; Suganami A; Tamura Y; Murayama T
Cell Signal; 2008 May; 20(5):815-24. PubMed ID: 18280113
[TBL] [Abstract][Full Text] [Related]
20. 1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.
Sundermann T; Fabian J; Hanekamp W; Lehr M
Bioorg Med Chem; 2015 May; 23(10):2579-92. PubMed ID: 25862211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
